Literature DB >> 16023897

Female, but not male, serotonin reuptake transporter (5-HTT) knockout mice exhibit bladder instability.

L L Cornelissen1, D P Brooks, A Wibberley.   

Abstract

Correlations exist between the incidence of depression, irritable bowel syndrome (IBS) and overactive bladder [Masand, P.S., Kaplan, D.S., Gupta, S., Bhandary, A.N., Nasra, G.S., Kline, M.D., Margo, K.L., 1995. Major depression and irritable bowel syndrome: is there a relationship? J. Clin. Psychiatry 56, 363-367.; Cukier, J.M., Cortina-Borja, M., Brading, A.F., 1997. A case-control study to examine any association between idiopathic detrusor instability and gastrointestinal tract disorder, and between irritable bowel syndrome and urinary tract disorder. Br. J. Urol. 79, 865-878.; Monga, A.K., Marrero, J.M., Stanton, S.L., Lemieux, M.C., Maxwell, J.D., 1997. Is there an irritable bladder in the irritable bowel syndrome? Br. J. Obstet. Gynaecol. 104, 1409-1412.; Zorn, B.H., Montgomery, H., Pieper, K., Gray, M., Steers, W.D., 1999. Urinary incontinence and depression. J. Urol. 162, 82-84.]. Furthermore, alterations in serotonergic neurotransmission may play a common role in the etiology of these disorders. Serotonin reuptake transporter knockout mice (5-HTT(-/-)) display phenotypes consistent with clinical features of mood and bowel disorders including anxiety and abnormal gastrointestinal motility [Holmes, A., Murphy, D.L., Crawley, J.N., 2003. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 54, 953-959.]. In the present study, we evaluated bladder function in 5-HTT(-/-) mice. We have found that female 5-HTT(-/-) mice exhibit bladder dysfunction, characterized by significant increases in the frequency of spontaneous non-voiding bladder contractions and decreases in void volume compared to control female mice. These differences were not observed in male knockout mice. These studies provide significant supporting data for a mechanistic link between alterations in 5-HT, depression, IBS and overactive bladder in women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023897     DOI: 10.1016/j.autneu.2005.06.005

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  10 in total

Review 1.  Genetic approaches to functional gastrointestinal disorders.

Authors:  Yuri A Saito; Nandita Mitra; Emeran A Mayer
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

Review 2.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

3.  Affective Temperament Profiles of Overactive Bladder Patients.

Authors:  Ali Saribacak; Kürşat Altinbaş; Hasan Yilmaz; Alp Özkan; Levend Özkan; Timuçin Oral
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

Review 4.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

Review 5.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

6.  Temporal ordering of interstitial cystitis/bladder pain syndrome and non-bladder conditions.

Authors:  J Quentin Clemens; Marc N Elliott; Marika Suttorp; Sandra H Berry
Journal:  Urology       Date:  2012-12       Impact factor: 2.649

7.  Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey.

Authors:  Heather J Litman; William D Steers; John T Wei; Varant Kupelian; Carol L Link; John B McKinlay
Journal:  Urology       Date:  2007-10-24       Impact factor: 2.649

Review 8.  Sex differences in the physiology and pharmacology of the lower urinary tract.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2013-02-08

9.  The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Authors:  Yong June Yang; Jun Sung Koh; Hyo Jung Ko; Kang Joon Cho; Joon Chul Kim; Soo-Jung Lee; Chi-Un Pae
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

10.  Demonstration of 5-HT(3) receptor function and expression in the mouse bladder.

Authors:  N Chetty; I M Coupar; R Chess-Williams; K P Kerr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-07-03       Impact factor: 3.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.